Perrigo PRGO
NYSE PRGO
$13.76 -0.20 (-1.43%)
At close: Aug 20, 2026 · 11:56 AM UTC

Perrigo (PRGO) Non-Current Deferred Tax Liability (2013 - 2026)

Perrigo (PRGO) posted quarterly Non-Current Deferred Tax Liability of $153.5 million for Q1 2026, down 18.87% year-over-year from $189.2 million in Q1 2025, and down 9.12% quarter-over-quarter from $168.9 million in Q4 2025.

Perrigo (PRGO) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has reported Non-Current Deferred Tax Liability for 14 consecutive years, with $153.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-Current Deferred Tax Liability fell 18.87% year-over-year to $153.5 million; the TTM figure through Mar 2026 stood at $153.5 million (down 18.87% YoY), while the FY2025 annual figure was $168.9 million, down 16.88% from the prior year.
  • Non-Current Deferred Tax Liability fell to $153.5 million in Q1 2026 per PRGO's latest filing, from $168.9 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $409.1 million in Q4 2022 and bottomed at $153.5 million in Q1 2026.
  • Historically, Non-Current Deferred Tax Liability has averaged $264.0 million across 5 years, with a median of $238.9 million in 2022.
  • Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability jumped 68.35% — and 2024, when it sank 38.81%.
  • Perrigo's Non-Current Deferred Tax Liability stood at $368.2 million in 2022, then slipped by 28.76% to $262.3 million in 2023, then fell by 22.53% to $203.2 million in 2024, then decreased by 16.88% to $168.9 million in 2025, then fell by 9.12% to $153.5 million in 2026.
  • Business Quant data shows PRGO's Non-Current Deferred Tax Liability at $153.5 million in Q1 2026, $168.9 million in Q4 2025, and $194.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.07 Bn 43.10 Bn -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn -
10 Perrigo 1.91 Bn 1.51 Bn 313.90 Mn

Historic Data

Download Data
DateValue
Jun 27, 2026 146.70 Mn
Jun 27, 2026 146.70 Mn
Mar 28, 2026 153.50 Mn
Mar 28, 2026 153.50 Mn
Dec 31, 2025 168.90 Mn
Dec 31, 2025 168.90 Mn
Sep 27, 2025 194.40 Mn
Sep 27, 2025 194.40 Mn
Jun 28, 2025 206.80 Mn
Jun 28, 2025 206.80 Mn
Mar 29, 2025 189.20 Mn
Mar 29, 2025 189.20 Mn
Dec 31, 2024 203.20 Mn
Dec 31, 2024 203.20 Mn
Sep 28, 2024 213.80 Mn
Sep 28, 2024 213.80 Mn
Jun 29, 2024 211.70 Mn
Jun 29, 2024 211.70 Mn
Mar 30, 2024 247.70 Mn
Mar 30, 2024 247.70 Mn